Kamalapuram Sishir K, Handral Harish, Choudhury Deepak
Sanjeevani BioServices Pvt Ltd., Hyderabad 500084, India.
Biomanufacturing Technology, Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, Singapore 138668, Singapore.
Foods. 2021 Nov 25;10(12):2922. doi: 10.3390/foods10122922.
The dietary protein requirements of almost 9.8 billion people need to be fulfilled in a healthy and sustainable manner by 2050. Meat consumption contributes to 35% of the total protein requirement of the Indian population. Meat intake needs to be sustainable and economical without causing food security and production issues. Consumption of meat in India is projected to rise with an increase in consumer incomes. Hence, novel alternative proteins, including cultured meat (CM) and plant-based meat (PBM), are being developed to satisfy the demand for meat-derived proteins in the diet. This involves the creation of novel PBM/CM products with a similar taste and texture as conventional animal meat with tailor-made nutritional attributes. In this article, we provide critical insights into the technical and business aspects of relevance to production and sustainability encountered by the Indian CM industry at a series of stages that can be termed the CM value chain comprising upstream and downstream processes. We shed light on the need for regulatory authorities and a framework. Consumer concerns towards CM products can be alleviated through effective scientific communication strategies, including prior familiarity, narrative building and transparency, and labelling aspects of CM products.
到2050年,近98亿人的膳食蛋白质需求需要以健康和可持续的方式得到满足。肉类消费占印度人口总蛋白质需求的35%。肉类摄入需要可持续且经济,同时不引发粮食安全和生产问题。预计随着消费者收入的增加,印度的肉类消费量将会上升。因此,包括细胞培养肉(CM)和植物基肉(PBM)在内的新型替代蛋白质正在被开发出来,以满足饮食中对肉类衍生蛋白质的需求。这涉及到创造出具有与传统动物肉相似的味道和质地,并具备定制营养属性的新型PBM/CM产品。在本文中,我们深入探讨了印度细胞培养肉行业在一系列可称为细胞培养肉价值链(包括上游和下游流程)的阶段中,在生产和可持续性方面所遇到的技术和商业相关关键问题。我们阐明了监管机构和框架的必要性。通过有效的科学沟通策略,包括预先熟悉、构建叙事和透明度以及细胞培养肉产品的标签方面,可以减轻消费者对细胞培养肉产品的担忧。